Abdulaziz Asiri

467 total citations
31 papers, 299 citations indexed

About

Abdulaziz Asiri is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Abdulaziz Asiri has authored 31 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Abdulaziz Asiri's work include Genomics and Rare Diseases (3 papers), Congenital heart defects research (3 papers) and Computational Drug Discovery Methods (3 papers). Abdulaziz Asiri is often cited by papers focused on Genomics and Rare Diseases (3 papers), Congenital heart defects research (3 papers) and Computational Drug Discovery Methods (3 papers). Abdulaziz Asiri collaborates with scholars based in Saudi Arabia, Egypt and India. Abdulaziz Asiri's co-authors include Muhammad Umair, Amer Al Ali, Mohammad Ilyas, Mater H. Mahnashi, Majid Alfadhel, Ibrahim Ahmed Shaikh, Teresa P. Raposo, Yusra Alyafee, Arun K. Shettar and Joy H. Hoskeri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Abdulaziz Asiri

26 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdulaziz Asiri Saudi Arabia 12 146 65 51 26 25 31 299
Martina Paumann-Page New Zealand 12 153 1.0× 27 0.4× 22 0.4× 18 0.7× 20 0.8× 19 437
Di Li China 9 138 0.9× 15 0.2× 25 0.5× 46 1.8× 33 1.3× 24 337
Xinjie Lin Canada 9 86 0.6× 26 0.4× 16 0.3× 38 1.5× 15 0.6× 15 264
Małgorzata Józkowiak Poland 12 162 1.1× 35 0.5× 34 0.7× 28 1.1× 48 1.9× 30 355
Ruonan Xu China 14 197 1.3× 20 0.3× 21 0.4× 57 2.2× 32 1.3× 33 389
Jiankun Yu China 13 277 1.9× 58 0.9× 13 0.3× 61 2.3× 22 0.9× 22 438
Krishna Priya Mani India 12 90 0.6× 12 0.2× 21 0.4× 24 0.9× 28 1.1× 16 319
Fereshteh Haghighi Germany 8 142 1.0× 26 0.4× 11 0.2× 35 1.3× 24 1.0× 9 272
Trần Thị Hải Yến Vietnam 8 145 1.0× 29 0.4× 21 0.4× 22 0.8× 11 0.4× 40 301
Weili Ma United States 9 146 1.0× 12 0.2× 22 0.4× 44 1.7× 20 0.8× 14 392

Countries citing papers authored by Abdulaziz Asiri

Since Specialization
Citations

This map shows the geographic impact of Abdulaziz Asiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulaziz Asiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulaziz Asiri more than expected).

Fields of papers citing papers by Abdulaziz Asiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulaziz Asiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulaziz Asiri. The network helps show where Abdulaziz Asiri may publish in the future.

Co-authorship network of co-authors of Abdulaziz Asiri

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulaziz Asiri. A scholar is included among the top collaborators of Abdulaziz Asiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulaziz Asiri. Abdulaziz Asiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kausar, Mohd Adnan, et al.. (2025). RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). International Journal of Oncology. 67(2). 1–16. 2 indexed citations
3.
Asiri, Abdulaziz, et al.. (2025). Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential. Frontiers in Pharmacology. 16. 1592395–1592395. 1 indexed citations
4.
5.
6.
Asiri, Abdulaziz. (2024). In-Silico Perspectives on the Potential Therapeutic Aids of Hesperetin Derivatives for Lung Cancer. Revista Catalana de Dret Públic. 11(4). 878–878.
7.
Mahnashi, Mater H., et al.. (2023). Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2203879–2203879. 5 indexed citations
8.
Asiri, Abdulaziz, et al.. (2023). Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review. Cureus. 15(9). e45019–e45019. 4 indexed citations
9.
Asiri, Abdulaziz, et al.. (2023). Satisfaction and anxiety level during clinical training among nursing students. BMC Nursing. 22(1). 187–187. 9 indexed citations
10.
Alrfaei, Bahauddeen M., Abdulaziz Asiri, Yahya Bokhari, et al.. (2023). Electrolytes Play a Role in Detecting Cisplatin-Induced Kidney Complications and May Even Prevent Them—Retrospective Analysis. Medicina. 59(5). 890–890. 3 indexed citations
11.
Assiri, Abdullah M., Manal Mustafa, Abdulaziz Asiri, et al.. (2023). Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort study.. PubMed. 27(20). 10076–10081. 1 indexed citations
12.
Barhoumi, Tlili, Abdulaziz Asiri, Marwan Nashabat, et al.. (2021). A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy. Scientific Reports. 11(1). 12861–12861. 11 indexed citations
13.
Alfadhel, Majid, Muhammad Umair, Bader Almuzzaini, et al.. (2021). Identification of the TTC26 Splice Variant in a Novel Complex Ciliopathy Syndrome with Biliary, Renal, Neurological, and Skeletal Manifestations. Molecular Syndromology. 12(3). 133–140. 8 indexed citations
14.
Asiri, Abdulaziz, Muhammad Umair, Yusra Alyafee, et al.. (2020). Mutated RAP1GDS1 causes a new syndrome of dysmorphic feature, intellectual disability & speech delay. Annals of Clinical and Translational Neurology. 7(6). 956–964. 16 indexed citations
15.
Bhat, Javaid Akhter, Marwan Nashabat, Yusra Alyafee, et al.. (2020). A Missense Mutation in the UGDH Gene Is Associated With Developmental Delay and Axial Hypotonia. Frontiers in Pediatrics. 8. 71–71. 18 indexed citations
16.
Mutairi, Fuad Al, Fayhan Alroqi, Yusra Alyafee, et al.. (2020). Homozygous truncating NEK10 mutation, associated with primary ciliary dyskinesia: a case report. BMC Pulmonary Medicine. 20(1). 141–141. 13 indexed citations
17.
Umair, Muhammad, Abdulaziz Asiri, Yusra Alyafee, et al.. (2020). EMC10 homozygous variant identified in a family with global developmental delay, mild intellectual disability, and speech delay. Clinical Genetics. 98(6). 555–561. 25 indexed citations
18.
19.
Umair, Muhammad, Amjad Khan, Safdar Abbas, et al.. (2019). Biallelic Missense Mutation in the ECEL1 Underlies Distal Arthrogryposis Type 5 (DA5D). Frontiers in Pediatrics. 7. 343–343. 13 indexed citations
20.
Asiri, Abdulaziz, et al.. (2018). TGF β1‐induced cell motility but not cell proliferation is mediated through Cten in colorectal cancer. International Journal of Experimental Pathology. 99(6). 323–330. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Paumann-Page Breakdown of academic impact, for papers by Di Li Breakdown of academic impact, for papers by Xinjie Lin Breakdown of academic impact, for papers by Małgorzata Józkowiak Breakdown of academic impact, for papers by Ruonan Xu Breakdown of academic impact, for papers by Jiankun Yu Breakdown of academic impact, for papers by Krishna Priya Mani Breakdown of academic impact, for papers by Fereshteh Haghighi Breakdown of academic impact, for papers by Trần Thị Hải Yến Breakdown of academic impact, for papers by Weili Ma
Rankless by CCL
2026